This is a preview of subscription content, log in via an institution to check access.
Reference
Naber SK, et al. Cost-effectiveness of inactivated influenza vaccination in children with medical risk conditions in the Netherlands. Vaccine : 27 Feb 2020. Available from: URL: http://dx.doi.org/10.1016/j.vaccine.2020.01.057
Rights and permissions
About this article
Cite this article
Influenza vaccine "unlikely" to be cost effective for high-risk children in The Netherlands. PharmacoEcon Outcomes News 849, 15 (2020). https://doi.org/10.1007/s40274-020-6666-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-6666-z